Auven Therapeutics Mergers and Acquisitions Summary

Private Equity Profile

Auven Therapeutics’ most common sector for investment is life science (100%). The Firm’s most common investment types include buyout (lbo, mbo, mbi) (50%) and venture (50%). In total, Auven Therapeutics has invested in 1 US state and 2 different countries.

The Firm’s most common exit type is trade sale (100%). Auven Therapeutics’ largest (disclosed) exit occurred in 2013 when it sold Spirogen for $240M.

Join Mergr to view Auven Therapeutics’ full profile and discover more small private equity firms just like it.

M&A Summary

  • M&A Total Activity4
    • M&A Buy Activity2
    • M&A Sell Activity2
  • Total Sectors Invested 1
  • Total Countries Invested 2
  • M&A Buy/Sell Connections 2
  • M&A Advisors 2

Auven Therapeutics

,
www.auventx.com

Auven Therapeutics is a private equity firm focused on investing in life science companies. Auven looks to acquire controlling ownership in promising therapeutic products or platforms and develop programs to selling them as clinically and commercially validated products to established pharmaceutical companies. Auven was established in 2007 and is headquartered in St. Thomas, US Virgin Islands.


Investment Criteria

Sectors of Interest: Healthcare Services, Life Science

Target Transaction Types: Buyout (LBO, MBO, MBI), Growth Capital

Geographic Preferences: East US, Midwest US, South US, West US

Transaction Criteria Min Max
Target Revenue - -
Target EBITDA - -
Investment Size - -
Enterprise Value - -

M&A Summary

Buy vs Sell

Year ≤ '15 '16 '17 '18 '19 '20 T
Buy (0.0/yr) # 2 - - - - - 2
Sell (0.2/yr) # 1 1 - - - - 2
vol $240M $40M $280M
  4

Most Recent M&A

Company Date Value Type
Ocular Technologies Sarl 2016-10-26 40M USD Add-on Acquisition
Lyme Park, South Africa · www.oculartechnologies.com
Spirogen Ltd. 2013-10-15 240M USD Add-on Acquisition
London, United Kingdom · www.spirogen.com
Kolltan Pharmaceuticals, Inc. 2010-01-19 - Venture
New Haven, Connecticut · www.kolltan.com
Spirogen Ltd. 2009-01-01 - Buyout (LBO, MBO, MBI)
London, United Kingdom · www.spirogen.com
View All >>

M&A by Sector

Sector Current # Value All-time # Value
Life Science - - 2 (100%) -
Total - - 2 -

Acquisitions By Geo

State/Country Current # Value All-time # Value
United States - - 1 (50%) -
  Connecticut - - 1 (50%) -
United Kingdom - - 1 (50%) -
Total - - 2 -

Acquisitions by Deal Type

Type Current # Value All-time # Value
Buyout (LBO, MBO, MBI) - - 1 (50%) -
Venture - - 1 (50%) -
Total - - 2 -

Exits by Deal Type

Type Total # Value
Trade Sale - Public Company 2 (100%) 280M (100%)
Total 2 $280M

Top M&A Advisors

Financial Deals
MTS Health Partners LP
1
Legal Deals
Akin Gump Strauss Hauer & Feld LLP
1

Deal Values

sell # Total
$100M to $1B 1 $240M
< $100M 1 $40M
TOTAL $280M
Largest Spirogen Ltd.
$240M (2013-10-15)

M&A Connections

Deals %
Exited to
Strategic(s)
100%
2 100%